Anthony P. Coll

Anthony P. Coll

Auto-generated profile, based on publicly available information

Anthony P. Coll

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2007 in Science
Verified
Journal Article
Closed access
PDF file
TGThomas Gerken
Thomas Gerken
Christophe GirardChristophe Girard
Christophe Girard
YTYi-Chun Loraine Tung
Yi-Chun Loraine Tung
CWCelia J. Webby
Celia J. Webby
VSVladimir Saudek
Vladimir Saudek
CSChristopher J. Schofield
Christopher J. Schofield
Variants in theFTO(fat mass and obesity associated) gene are associated with increased body mass index in humans. Here, we show by bioinformatics analysis that FTO shares sequence motifs with Fe(II)- and 2-oxoglutarate–dependent oxygenases. We find that recombinant murine Fto catalyzes the Fe(II)- and 2OG-dependent demethylation of 3-methylthymine in single-stranded DNA, with concomitant production of succinate, formaldehyde, and carbon dioxide. Consistent with a potential role in nucleic acid demethylation, Fto localizes to the nucleus in transfected cells. Studies of wild-type mice indicate thatFtomessenger RNA (mRNA) is most abundant in the brain, particularly in hypothalamic nuclei governing energy balance, and thatFtomRNA levels in the arcuate nucleus are regulated by feeding and fasting. Studies can now be directed toward determining the physiologically relevant FTO substrate and how nucleic acid methylation status is linked to increased fat mass.

25 December 2019 in Nature
Verified
Journal Article
Closed access
PDF file
ACAnthony P. Coll
Anthony P. Coll
MCMichael Chen
Michael Chen
PTPranali Taskar
Pranali Taskar
DRDebra Rimmington
Debra Rimmington
SPSatish Patel
Satish Patel
SOStephen O’rahilly
Stephen O’rahilly

1 April 2007 in Cell
Verified
Journal Article
Open access
ACAnthony P. Coll
Anthony P. Coll
IFI. Sadaf Farooqi
I. Sadaf Farooqi
SOStephen O'Rahilly
Stephen O'Rahilly
Numerous circulating peptides and steroids produced in the body influence appetite through their actions on the hypothalamus, the brain stem, and the autonomic nervous system. These hormones come from three major sites-fat cells, the gastrointestinal tract, and the pancreas. In this Review we provide a synthesis of recent evidence concerning the actions of these hormones on food intake.

27 May 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
EREdward W. Roberts
Edward W. Roberts
ADAndrew Deonarine
Andrew Deonarine
JJJames O. Jones
James O. Jones
ADAlice E. Denton
Alice E. Denton
CFChristine Feig
Christine Feig
DFDouglas T. Fearon
Douglas T. Fearon
Fibroblast activation protein-α (FAP) identifies stromal cells of mesenchymal origin in human cancers and chronic inflammatory lesions. In mouse models of cancer, they have been shown to be immune suppressive, but studies of their occurrence and function in normal tissues have been limited. With a transgenic mouse line permitting the bioluminescent imaging of FAP+ cells, we find that they reside in most tissues of the adult mouse. FAP+ cells from three sites, skeletal muscle, adipose tissue, and pancreas, have highly similar transcriptomes, suggesting a shared lineage. FAP+ cells of skeletal muscle are the major local source of follistatin, and in bone marrow they express Cxcl12 and KitL. Experimental ablation of these cells causes loss of muscle mass and a reduction of B-lymphopoiesis and erythropoiesis, revealing their essential functions in maintaining normal muscle mass and hematopoiesis, respectively. Remarkably, these cells are altered at these sites in transplantable and spontaneous mouse models of cancer-induced cachexia and anemia. Thus, the FAP+ stromal cell may have roles in two adverse consequences of cancer: their acquisition by tumors may cause failure of immunosurveillance, and their alteration in normal tissues contributes to the paraneoplastic syndromes of cachexia and anemia.

1 November 2016 in Cell Metabolism
Verified
Journal Article
Open access
TFThomas R. Flint
Thomas R. Flint
TJTobias Janowitz
Tobias Janowitz
CCClaire M. Connell
Claire M. Connell
EREdward W. Roberts
Edward W. Roberts
ADAlice E. Denton
Alice E. Denton
DFDouglas T. Fearon
Douglas T. Fearon
In patients with cancer, the wasting syndrome, cachexia, is associated with caloric deficiency. Here, we describe tumor-induced alterations of the host metabolic response to caloric deficiency that cause intratumoral immune suppression. In pre-cachectic mice with transplanted colorectal cancer or autochthonous pancreatic ductal adenocarcinoma (PDA), we find that IL-6 reduces the hepatic ketogenic potential through suppression of PPARalpha, the transcriptional master regulator of ketogenesis. When these mice are challenged with caloric deficiency, the resulting relative hypoketonemia triggers a marked rise in glucocorticoid levels. Multiple intratumoral immune pathways are suppressed by this hormonal stress response. Moreover, administering corticosterone to elevate plasma corticosterone to a level that is lower than that occurring in cachectic mice abolishes the response of mouse PDA to an immunotherapy that has advanced to clinical trials. Therefore, tumor-induced IL-6 impairs the ketogenic response to reduced caloric intake, resulting in a systemic metabolic stress response that blocks anti-cancer immunotherapy.

15 March 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
BCB. G. Challis
B. G. Challis
ACA. P. Coll
A. P. Coll
GYG. S. H. Yeo
G. S. H. Yeo
SPS. B. Pinnock
S. B. Pinnock
SDSuzanne Dickson
Suzanne Dickson
SOS. O'RAhilly
S. O'RAhilly
Inactivating mutations of the pro-opiomelanocortin (POMC) gene in both mice and humans leads to hyperphagia and obesity. To further examine the mechanisms whereby POMC-deficiency leads to disordered energy homeostasis, we have generated mice lacking all POMC-derived peptides. Consistent with a previously reported model, Pomc -/- mice were obese and hyperphagic. They also showed reduced resting oxygen consumption associated with lowered serum levels of thyroxine. Hypothalami from Pomc -/- mice showed markedly increased expression of melanin-concentrating hormone mRNA in the lateral hypothalamus, but expression of neuropeptide Y mRNA in the arcuate nucleus was not altered. Provision of a 45% fat diet increased energy intake and body weight in both Pomc -/- and Pomc +/- mice. The effects of leptin on food intake and body weight were blunted in obese Pomc -/- mice whereas nonobese Pomc -/- mice were sensitive to leptin. Surprisingly, we found that Pomc -/- mice maintained their acute anorectic response to peptide-YY 3-36 (PYY 3-36 ). However, 7 days of PYY 3-36 administration had no effect on cumulative food intake or body weight in wild-type or Pomc -/- mice. Thus, POMC peptides seem to be necessary for the normal response of energy balance to high-fat feeding, but not for the acute anorectic effect of PYY 3-36 or full effects of leptin on feeding. The finding that the loss of only one copy of the Pomc gene is sufficient to render mice susceptible to the effects of high fat feeding emphasizes the potential importance of this locus as a site for gene-environment interactions predisposing to obesity.